Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Novartis
Fish and Richardson
Queensland Health
Covington
Citi
Colorcon
Merck
Dow
US Army

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,208,256

« Back to Dashboard

Summary for Patent: 5,208,256
Title: Treatment of ocular hypertension with a synergistic combination for ocular administration
Abstract:A method for treatment of ocular hypertension which comprises ocularly administering, to a subject in need of such treatment, an oculo-hypotensively synergistic combination of (a) a 13,14-dihydro-15-keto-20-loweralkylprostaglandin or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable ester thereof, and (b) a polyoxyethylenesorbitan unsaturated higher aliphatic acid monoester in an amount effective in treatment of ocular hypertension.
Inventor(s): Ueno; Ryuji (Hyogo, JP)
Assignee: R-Tech Ueno, Ltd. (Osaka, JP)
Application Number:07/703,660
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 5,208,256

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,208,256

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2-132909May 22, 1990

International Patents Family Members for US Patent 5,208,256

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2042972 ➤ Try a Free Trial
Germany 69105349 ➤ Try a Free Trial
Denmark 0458588 ➤ Try a Free Trial
Austria 114470 ➤ Try a Free Trial
European Patent Office 0458588 ➤ Try a Free Trial
Spain 2067864 ➤ Try a Free Trial
Japan H04253910 ➤ Try a Free Trial
Japan H0798751 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
US Department of Justice
Dow
Boehringer Ingelheim
Mallinckrodt
US Army
Merck
Fuji
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot